IDH1 and central nervous system cancer: The low expression of miR-155 in IDH1-mutant glioma can upregulate the expression of FAM133A, which may further reduce the invasiveness and proliferation of IDH1-mutant glioma by targeting Matrix metalloproteinase-14 (MMP14) (60).